NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
Globus Medical, Inc. GMED
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.9B
▲ 16.7% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
12.3%
Net margin · FY25
18.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.9B
Revenue, FY2025 · full 16-year series below
Revenue
Net income
18 cents of every revenue dollar became profit this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
12.3%
Return on equity, FY2025
ROE
Operating margin16.3%
Net margin18.3%
Return on assets10.2%
Each USD of equity produced 12 cents of profit this year.
Returned to shareholders
USD 210.7M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 210.7M
Share of profit39.2%
Consecutive raises—
USD 210.7M in buybacks — 39% of the year's profit went back to shareholders.
Growth
+30.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+42.2%
+30.1%
+18.4%
+16.7%
Net income
+41.4%
+39.4%
+16.9%
+16.5%
EPS, diluted
+28.4%
+31.2%
+12.9%
+13.3%
Returned to shareholders
+27.0%
+45.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years+5.4%
Change, 10 years—
The share count grew 5% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.3B
total assets, end of FY2025
Total assetsUSD 5.3B
EquityUSD 4.6B
CashUSD 526.2M
Current ratio4.26×
Equity funds 86% of total assets.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
2.9
2.5
1.6
1.0
1.0
0.8
0.8
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.3
0.3
Operating income $B
0.5
0.2
0.1
0.2
0.2
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
EBITDA $B
0.8
0.4
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
Income tax $B
0.1
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
Net income $B
0.5
0.1
0.1
0.2
0.1
0.1
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EPS, diluted $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
12.3
2.5
4.2
10.6
9.2
7.0
12.0
14.5
11.9
13.5
17.3
17.5
16.0
22.1
23.8
23.9
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
60 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed